HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Non-Hodgkin's malignant lymphomas in primates (immunodiagnostic principles in T-cell lymphomas)].

Abstract
Morphological and immunological phenotyping was carried out on 20 cases of peripheral baboon T-cell non-Hodgkin's malignant lymphomas (NHL) observed in a Sukhumi monkey colony. Morphologically, the lymphomas were prolymphocytic, immunoblastic, or rarely lymphoblastic types. For immunophenotyping studies, the panel of 29 monoclonal antibodies (MAb) to human or mouse leukocytic antigens were used (18 CD clusters). Three polyclonal sera to human IgG and light chains kappa and lambda were also taken in experiments. The investigated NHLs and CD4+CD8- (12 cases) or CD4-CB8+ (5 cases) phenotypes. In some cases loss of pan T-cell antigens or unusual antigen expression--loss (one case) or coexpression (two cases) of T-subset antigens--or the presence of abnormal lymphoid antigens have been revealed. In most studies, baboon T-cell NHLs tumor cells belonged to activated T-cells because they expressed Ia-like antigens and IL2R at high levels. There was no correlation between the discovered immunophenotype and the morphological pattern of malignant lymphomas.
AuthorsL V Indzhiia, L A Iakovleva, M G Chikobava, M Valentaĭn, B A Lapin, E Klark
JournalVestnik Akademii meditsinskikh nauk SSSR (Vestn Akad Med Nauk SSSR) Issue 9 Pg. 21-7 ( 1990) ISSN: 0002-3027 [Print] Russia (Federation)
Vernacular TitleNekhodzhkinskie zlokachestvennye limformy v otriade primatov (printsipy immunodiagnostiki T-kletochnykh limfom).
PMID2264382 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Histocompatibility Antigens Class II
Topics
  • Animals
  • Antibodies, Monoclonal
  • Female
  • Histocompatibility Antigens Class II (analysis)
  • Immunologic Tests
  • Immunophenotyping
  • Lymphoma, T-Cell (diagnosis, immunology, pathology)
  • Male
  • Papio
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: